From the Leibniz-Institut für Molekulare Pharmakologie (FMP) and.
J Biol Chem. 2013 Oct 4;288(40):28611-9. doi: 10.1074/jbc.M113.509364. Epub 2013 Aug 27.
CLC anion transporters form dimers that function either as Cl(-) channels or as electrogenic Cl(-)/H(+) exchangers. CLC channels display two different types of "gates," "protopore" gates that open and close the two pores of a CLC dimer independently of each other and common gates that act on both pores simultaneously. ClC-7/Ostm1 is a lysosomal 2Cl(-)/1H(+) exchanger that is slowly activated by depolarization. This gating process is drastically accelerated by many CLCN7 mutations underlying human osteopetrosis. Making use of some of these mutants, we now investigate whether slow voltage activation of plasma membrane-targeted ClC-7/Ostm1 involves protopore or common gates. Voltage activation of wild-type ClC-7 subunits was accelerated by co-expressing an excess of ClC-7 subunits carrying an accelerating mutation together with a point mutation rendering these subunits transport-deficient. Conversely, voltage activation of a fast ClC-7 mutant could be slowed by co-expressing an excess of a transport-deficient mutant. These effects did not depend on whether the accelerating mutation localized to the transmembrane part or to cytoplasmic cystathionine-β-synthase (CBS) domains of ClC-7. Combining accelerating mutations in the same subunit did not speed up gating further. No currents were observed when ClC-7 was truncated after the last intramembrane helix. Currents and slow gating were restored when the C terminus was co-expressed by itself or fused to the C terminus of the β-subunit Ostm1. We conclude that common gating underlies the slow voltage activation of ClC-7. It depends on the CBS domain-containing C terminus that does not require covalent binding to the membrane domain of ClC-7.
CLC 阴离子转运蛋白形成二聚体,这些二聚体可作为 Cl(-) 通道或作为生电性 Cl(-)/H(+)交换器发挥作用。CLC 通道显示出两种不同类型的"门",即"原孔"门,其可以独立地打开和关闭 CLC 二聚体的两个孔,以及共同的门,其同时作用于两个孔。ClC-7/Ostm1 是溶酶体的 2Cl(-)/1H(+)交换器,其通过去极化而缓慢激活。许多导致人类成骨不全症的 CLCN7 突变极大地加速了这种门控过程。利用其中一些突变,我们现在研究了质膜靶向 ClC-7/Ostm1 的缓慢电压激活是否涉及原孔或共同门。野生型 ClC-7 亚基的电压激活通过与使这些亚基运输缺陷的点突变一起过量表达携带加速突变的 ClC-7 亚基而加速。相反,通过过量表达运输缺陷的突变体,可使快速 ClC-7 突变体的电压激活减慢。这些效应不取决于加速突变位于 ClC-7 的跨膜部分还是细胞质半胱氨酸-β-合酶 (CBS) 结构域。在相同的亚基中组合加速突变不会进一步加快门控。当 ClC-7 在最后一个跨膜螺旋之后截断时,没有观察到电流。当 C 末端本身共表达或融合到 Ostm1 的β亚基的 C 末端时,会恢复电流和缓慢门控。我们得出结论,共同门控是 ClC-7 缓慢电压激活的基础。它依赖于包含 CBS 结构域的 C 末端,该末端不需要与 ClC-7 的膜结构域共价结合。